Cancer Center Research Programs
The Huntsman Cancer Institute at the University of Utah (HCI) is a National Cancer Institute-Designated Cancer Center. The Cancer Center Support Grant (CCSG) provides funding for four research programs, each focused on a specialized aspect of basic, translational, and clinical cancer research performed by more than 135 members of our Cancer Center. These programs promote scientific excellence through coordinated, broad-based transdisciplinary research.
- Cancer Center Directory
The Shared Resources at HCI and the University of Utah are funded by a combination of the Cancer Center Support Grant (CCSG), HCI institutional funds, other University of Utah funding sources, and charge-back for services. The HCI Shared Resources are overseen by Brad Cairns (Research Informatics, High-Throughput Genomics and Bioinformatic Analysis), David Jones (Biorepository and Molecular Pathology), Ken Boucher (Cancer Biostatistics), Wendy Kohlmann (Genetic Counseling), Ken Smith (Utah Population Database), Sunil Sharma (Clinical Trials Office), as well as Scott Lloyd who provides general financial and administrative oversight. University of Utah Health's shared resources are overseen by Andrew Weyrich and John Phillips.
Disease Oriented Research Teams (DOTs)
HCI leadership has made a strategic commitment to develop disease oriented research teams (DOTs) as a mechanism to enhance cancer focus, transdisciplinary integration, and collaboration. The ultimate objective of the DOT program is to maximize the impact of HCI discoveries on cancer patients.
Research Labs and Groups
The collaborative research approach between doctors and scientists, with an emphasis on investigating the genetic basis of cancer, makes HCI one of the leading cancer research organizations in the country.
Knowledge of the genetic basis of cancer is essential to understanding the disease. Genetic data is important in all aspects of cancer management.
The key to finding new and better treatments for cancer lies in research. The HCI Clinical Trials Office (CTO) continually develops new approaches to help cancer patients live longer and better lives. Patient participation in clinical trials is an essential factor in this process.
HCI continuously searches for world-class research and clinical faculty.
High Risk Cancer Research Clinics and Studies
The High Risk Cancer Research Clinics provide information for investigations into the genetics and inheritance of cancer. They provide education, and in some cases cancer screening services, for individuals and families with an increased risk of developing cancer. Through these clinics, eligible participants may enroll in cancer research studies. Physicians, genetic counselors, research coordinators, and other support personnel provide a multidisciplinary approach to patient care.
Center for Quantitative Cancer Imaging
HCI provides researchers, clinicians, and the people of Utah with the most advanced molecular imaging technologies to enable the highest quality research and assist clinicians in diagnosing disease and monitoring therapy.
HCI supports major population studies concerned with prevention, screening, and origins of several types of cancer.
Training and Education
Educating the next generation of cancer researchers and physicians is one of the goals at HCI. Our training opportunities bring together students, faculty, and staff in an atmosphere of learning and collaboration between a wide range of research disciplines.